FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Manuel López-Brea

Research Profile

Living Beings

Procedures

Chemicals & Drugs

Disorders

Physiology

Geographic Areas

Spain

Concepts & Ideas

Virulence

Co-author Network

Publications

TOP 3
A Guiu; A Correa; Diego Domingo; Manuel López-Brea
[Leptotrichia goodfellowii wound infection after a dog bite].
Ana María Correa; Carmen de Las Cuevas; Diego Domingo; Alba Guiu; Teresa Alarcón; Juan Carlos Sanz; Manuel López-Brea
[Pneumococcal bacteremia in adult patients at a hospital in Madrid: serotypes and susceptibility].
S Agudo; G Pérez-Pérez; Teresa Alarcón; Manuel López-Brea
Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Manuel López-Brea (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A Guiu; A Correa; Diego Domingo; Manuel López-Brea
[Leptotrichia goodfellowii wound infection after a dog bite].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2012;25(3):220-1.
2012: Ana María Correa; Carmen de Las Cuevas; Diego Domingo; Alba Guiu; Teresa Alarcón; Juan Carlos Sanz; Manuel López-Brea
[Pneumococcal bacteremia in adult patients at a hospital in Madrid: serotypes and susceptibility].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2012;25(2):155-60.
2011: S Agudo; G Pérez-Pérez; Teresa Alarcón; Manuel López-Brea
Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2011;24(1):32-6.
2010: Marina Espínola; Angela Somodevilla; Diego Domingo; Teresa Alarcón; Manuel López-Brea
[Antibiotic susceptibility of Corynebacterium macginleyi strains causing conjunctivitis].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2010;23(4):196-200.
2010: Sonia Agudo; Guillermo Pérez-Pérez; Teresa Alarcón; Manuel López-Brea
High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain.
Journal of clinical microbiology 2010;48(10):3703-7.
2010: Sonia Agudo; Teresa Alarcón; Pedro Urruzuno; María Josefa Martínez; Manuel López-Brea
Detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies of pediatric patients by using a commercially available real-time polymerase chain reaction after NucliSens semiautomated DNA extraction.
Diagnostic microbiology and infectious disease 2010;67(3):213-9.
2008: Manuel López-Brea; Teresa Alarcón; Diego Domingo; Jazmín Díaz-Regañón
Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
The Journal of antimicrobial chemotherapy 2008;61(1):139-42.
2007: Alba E Vega; Teresa Alarcón; Diego Domingo; Manuel López-Brea
Detection of clarithromycin-resistant Helicobacter pylori in frozen gastric biopsies from pediatric patients by a commercially available fluorescent in situ hybridization.
Diagnostic microbiology and infectious disease 2007;59(4):421-3.
2007: E Aznar; T Alarcon; B Buendía; E García-Peñuela; Manuel López-Brea
Detection of decreased susceptibility to fluoroquinolones in Salmonella spp. by five different methods including real-time polymerase chain reaction (PCR).
International journal of antimicrobial agents 2007;30(1):67-71.
2006: Ana Pérez de Ayala-Balzola; Buenaventura Buendía-Moreno; Rosa M Girón-Moreno; Manuel López-Brea
[Pandoraea pulmonicola isolation in patients with cystic fibrosis].
Enfermedades infecciosas y microbiología clínica 2006;24(7):473-4.
2006: E García-Peñuela; E Aznar; T Alarcón; Manuel López-Brea
[Susceptibility pattern of Acinetobacter baumannii clinical isolates in Madrid vs. Hong Kong].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2006;19(1):45-50.
2006: J Díaz-Reganon; Teresa Alarcón; Diego Domingo; Manuel López-Brea
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2006;19(1):34-8.
2005: Teresa Alarcón; P de la Obra; Diego Domingo; J A García-Campos; J Díaz-Regañón; Manuel López-Brea
[In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2005;18(4):313-8.
2005: E Aznar; Diego Domingo; S Abanades; E García-Peñuela; Manuel López-Brea
[Resistance of Mycobacterium tuberculosis in a four-year period in a Madrid hospital].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2005;18(3):222-5.
2004: E Aznar; B Buendía; E García-Peñuela; E Escudero; T Alarcón; Manuel López-Brea
Community-acquired urinary tract infection caused by vancomycin-resistant Enterococcus faecalis clinical isolate.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2004;17(3):263-5.
2003: Diego Domingo; Manuel López-Brea
[Plants with antimicrobial action].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2003;16(4):385-93.
2003: J A García-Campos; Teresa Alarcón; Diego Domingo; M Menéndez-Rivas; Manuel López-Brea
[Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2003;16(2):216-20.
2003: A Perkins; S Osorio; M Serrano; M C del Ray; C Sarriá; Diego Domingo; Manuel López-Brea
A case of endocarditis due to Granulicatella adiacens.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(6):576-7.
2003: Alba E Vega; Teresa Alarcón; Diego Domingo; María Josefa Martínez; Manuel López-Brea
[Detection of resistance to clarithromycin in clinical isolates of Helicobacter pylori from children and adults].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2003;16(1):53-7.
2003: Teresa Alarcón; Alba E Vega; Diego Domingo; María Josefa Martínez; Manuel López-Brea
Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis.
Journal of clinical microbiology 2003;41(1):486-99.
2002: Teresa Alarcón; Diego Domingo; N Prieto; P de la Obra; Manuel López-Brea
[In vitro activity of clarithromycin and metronidazole against Helicobacter pylori in different incubation atmospheres].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2002;15(4):341-5.
2002: Diego Domingo; Teresa Alarcón; Alba E Vega; José Angel García; María Josefa Martínez; Manuel López-Brea
[Microbiological factors that influence the eradication of Helicobacter pylori in adults and children].
Enfermedades infecciosas y microbiología clínica 2002;20(9):431-4.
2002: P Vargas; Manuel López-Brea
[Present perspectives on Creutzfeldt-Jakob disease: pathogenesis, diagnosis and treatment].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2002;15(3):225-32.
2002: Youri Glupczynski; N Broutet; A Cantagrel; L P Andersen; T Alarcon; Manuel López-Brea; F Mégraud
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(7):549-52.
2002: José María Saugar; Teresa Alarcón; Susana López-Hernández; Manuel López-Brea; David Andreu; Luis Rivas
Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii.
Antimicrobial agents and chemotherapy 2002;46(3):875-8.
2001: Manuel López-Brea; María Josefa Martínez; Diego Domingo; Teresa Alarcón
A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children.
The Journal of antimicrobial chemotherapy 2001;48(2):295-7.
2001: Teresa Alarcón; Susana López-Hernández; David Andreu; José María Saugar; Luis Rivas; Manuel López-Brea
In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2001;14(2):184-90.
2001: Susana López-Hernández; Teresa Alarcón; Manuel López-Brea
Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(4):218-26.
2001: B Buendía; Manuel López-Brea
[What should we know about Aspergillus?].
Enfermedades infecciosas y microbiología clínica 2001;19(3):142-4.
2000: Manuel López-Brea; Diego Domingo; Teresa Alarcón
[In vitro activity of ascorbic acid].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2000;13(4):408-11.
2000: Susana López-Hernández; Teresa Alarcón; Manuel López-Brea
[Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2000;13(4):394-400.
2000: Diego Domingo; Manuel López-Brea
[Current and future perspectives in the microbiological diagnosis of Mycobacterium tuberculosis].
Enfermedades infecciosas y microbiología clínica 2000;18(9):488-90.
2000: Teresa Alarcón; Diego Domingo; N Prieto; Manuel López-Brea
Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA.
The Journal of antimicrobial chemotherapy 2000;46(4):613-6.
2000: Teresa Alarcón; M J Martínez; P Urruzuno; M L Cilleruelo; D Madruga; M Sebastian; Diego Domingo; Juan Carlos Sanz; Manuel López-Brea
Prevalence of CagA and VacA antibodies in children with Helicobacter pylori-associated peptic ulcer compared to prevalence in pediatric patients with active or nonactive chronic gastritis.
Clinical and diagnostic laboratory immunology 2000;7(5):842-4.
2000: S López; Manuel López-Brea
[What should be done for Acinetobacter baumannii infections?].
Enfermedades infecciosas y microbiología clínica 2000;18(3):153-6.
2000: Juan Carlos Sanz; Marisa Fernández; María Jesús Sagües; Rosa Ramírez; Luis García-Comas; Manuel López-Brea
[Age-dependent seroprevalence of Helicobacter pylori in children and adolescents in the community of Madrid].
Enfermedades infecciosas y microbiología clínica 2000;18(3):147-8.
2000: A Limia; Teresa Alarcón; ML Jiménez; Manuel López-Brea
Comparison of three methods for identification of Streptococcus milleri group isolates to species level.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(2):128-31.
2000: Teresa Alarcón; Diego Domingo; N Prieto; Manuel López-Brea
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.
Journal of clinical microbiology 2000;38(2):923-5.
1999: D Dámaso; Teresa Alarcón; N Prieto; Manuel López-Brea
[Relationship between antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(4):340-5.
1999: Manuel López-Brea; Teresa Alarcón
[Peptides of eukaryotic origin with antimicrobial activity].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(4):300-9.
1999: Teresa Alarcón; P de la Obra; S López-Hernandez; C de las Cuevas; Manuel López-Brea
[In vitro activity of piperacillin-tazobactam against Klebsiella pneumoniae clinical isolates, producers or not of extended spectrum beta-lactamases].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(3):229-33.
1999: Diego Domingo; Teresa Alarcón; Juan Carlos Sanz; H Villar; J M Hernández; J Sánchez; Manuel López-Brea
[The Helicobacter pylori adhesion gene: relation with the origin of the isolates and associated disease].
Enfermedades infecciosas y microbiología clínica 1999;17(7):342-6.
1999: Susana López-Hernández; Teresa Alarcón; T Delgado; M C de Las Cuevas; Manuel López-Brea
[In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(2):140-3.
1999: A Limia; ML Jiménez; Teresa Alarcón; Manuel López-Brea
Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):440-4.
1999: Manuel López-Brea; N Prieto; Diego Domingo; C de las Cuevas; I Sánchez; Teresa Alarcón
In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates.
International journal of antimicrobial agents 1999;12(1):33-9.
1999: Teresa Alarcón; Diego Domingo; Manuel López-Brea
Antibiotic resistance problems with Helicobacter pylori.
International journal of antimicrobial agents 1999;12(1):19-26.
1999: Diego Domingo; Teresa Alarcón; N Prieto; I Sánchez; Manuel López-Brea
cagA and vacA status of Spanish Helicobacter pylori clinical isolates.
Journal of clinical microbiology 1999;37(6):2113-4.
1999: Teresa Alarcón; Diego Domingo; M J Martinez; Manuel López-Brea
cagA gene and vacA alleles in Spanish Helicobacter pylori clinical isolates from patients of different ages.
FEMS immunology and medical microbiology 1999;24(2):215-9.
1999: Manuel López-Brea; M J Martínez; Diego Domingo; I Sánchez; Teresa Alarcón
Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population.
FEMS immunology and medical microbiology 1999;24(2):183-8.
1999: Teresa Alarcón; Diego Domingo; N Prieto; Manuel López-Brea
Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(1):64-8.
1998: Teresa Alarcón; Juan Carlos Sanz; F Blanco; Diego Domingo; Manuel López-Brea
High-level mupirocin resistance among Spanish methicillin-resistant Staphylococcus aureus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(12):877-9.
1998: Teresa Alarcón; Diego Domingo; Juan Carlos Sanz; María Josefa Martínez; Manuel López-Brea
[Use of the polymerase chain reaction (PCR) for the diagnosis of Helicobacter pylori infection in pediatric patients].
Enfermedades infecciosas y microbiología clínica 1998;16(9):395-9.
1998: Manuel López-Brea; Diego Domingo
[Advantages and disadvantages of an antibiotic policy].
Enfermedades infecciosas y microbiología clínica 1998;16(8):353-5.
1998: A Limia; ML Jiménez; T Delgado; I Sánchez; S López; Manuel López-Brea
[Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1998;11(3):216-20.
1998: Manuel López-Brea; Diego Domingo; I Sánchez; N Prieto; Teresa Alarcón
Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
The Journal of antimicrobial chemotherapy 1998;42(3):309-14.
1998: Manuel López-Brea; Teresa Alarcón; Diego Domingo; I Sánchez; María Josefa Martínez; Juan Carlos Sanz
[Evaluation of a western blot technique (Helicoblot 2.0) fpr the detection of specific Heliocobacter pylori antigens in children)].
Enfermedades infecciosas y microbiología clínica 1998;16(6):275-9.
1998: Manuel López-Brea; Teresa Alarcón; S López
[Microbiological and therapeutic considerations of Acinetobacter spp. infection].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1998;11(2):110-7.
1998: Teresa Alarcón; Diego Domingo; M C del Rey; S López; I Sánchez; Manuel López-Brea
In vitro activity of mupirocin against methicillin-resistant Staphylococcus aureus isolated from a hospital in Spain.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(6):398-9.
1998: Diego Domingo; Teresa Alarcón; Juan Carlos Sanz; I Sánchez; Manuel López-Brea
High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain.
The Journal of antimicrobial chemotherapy 1998;41(5):573-4.
1998: Susana López-Hernández; Teresa Alarcón; Manuel López-Brea
Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(4):282-5.
1998: Teresa Alarcón; Diego Domingo; I Sánchez; Juan Carlos Sanz; M J Martínez; Manuel López-Brea
In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(4):275-7.
1998: Teresa Alarcón; Diego Domingo; Manuel López-Brea
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori.
Journal of clinical microbiology 1998;36(4):1165-6.
1998: Teresa Alarcón; Diego Domingo; N Prieto; S Sánchez; Manuel López-Brea
[In vitro activity of trovafloxacin in 238 respiratory pathogens].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1998;11(1):47-51.
1998: E Muñoz de Bustillo; José A Sánchez-Tomero; Juan Carlos Sanz; J A Moreno; I Jiménez; Manuel López-Brea; J M Pajares; Juan Antonio Traver
Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients.
Nephron 1998;79(1):55-60.
1997: Manuel López-Brea; Diego Domingo; I Sanchez; T Alarcon
Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain.
The Journal of antimicrobial chemotherapy 1997;40(2):279-81.
1997: M I García-Arata; P Gerner-Smidt; Manuel López-Brea
Epidemiological study of Acinetobacter species isolated from an intensive care unit.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1997;105(2):131-8.
1996: Teresa Alarcón; Diego Domingo; I Sánchez; F Díaz de Rojas; Manuel López-Brea
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(12):937-40.
1996: M I García-Arata; M J Otero; M Zomeño; M A de la Figuera; M C de las Cuevas; Manuel López-Brea
Scedosporium apiospermum pneumonia after autologous bone marrow transplantation.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(7):600-3.
1996: M I García-Arata; T Alarcón; Manuel López-Brea
Emergence of resistant isolates of Acinetobacter calcoaceticus- A. baumannii complex in a Spanish hospital over a five-year period.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(6):512-5.
1996: B Buendía; T Delgado; S López; P Vallejo; M C del Rey; Manuel López-Brea
[Transient bacteremia caused by Corynebacterium urealyticum: apropos of 2 cases].
Enfermedades infecciosas y microbiología clínica 1996;14(6):367-9.
1996: Teresa Alarcón; Manuel López-Brea
[Mechanism of action and resistance to fluoroquinolones].
Enfermedades infecciosas y microbiología clínica 1996;14(2):111-7.
1995: Manuel López-Brea; Teresa Alarcón
[Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
Enfermedades infecciosas y microbiología clínica 1995;13(7):422-8.
1994: Manuel López-Brea; P Vallejo
[Intestinal parasitosis in the 90s: new microorganisms in new patients].
Revista clínica española 1994;194(5):348-51.
1994: Manuel López-Brea
[Antimicrobial sensitivity of Helicobacter pyloriø].
Enfermedades infecciosas y microbiología clínica 1994;12 Suppl 1():32-5.
1994: Diego Domingo; A Limia; Teresa Alarcón; Juan Carlos Sanz; M C Del Rey; Manuel López-Brea
Nosocomial septicemia caused by Serratia plymuthica.
Journal of clinical microbiology 1994;32(2):575-7.
1993: Teresa Alarcón; J Pita; Manuel López-Brea; L J Piddock
High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
The Journal of antimicrobial chemotherapy 1993;32(4):605-9.
1993: Juan Carlos Sanz; E Martín; Teresa Alarcón; María Josefa Martínez; M D García-Novo; Manuel López-Brea
[Evaluation of the cut-off point in the serological diagnosis of Helicobacter pylori infection in children using an enzyme immunoassay technique].
Enfermedades infecciosas y microbiología clínica 1993;11(1):55.
1993: Manuel López-Brea; E Martín; Teresa Alarcón; M D Acuña; M Gimeno; Juan Carlos Sanz
[Follow-up of the quantitative serological response to the treatment of Helicobacter pylori infection in children].
Enfermedades infecciosas y microbiología clínica 1993;11(1):33-5.
1992: M I García-Arata; P Vallejo; P Bermúdez; M L Jiménez; M C del Rey; Manuel López-Brea
[Significant bacteremias not detected by the BACTEC NR 730 system].
Enfermedades infecciosas y microbiología clínica 1992;10(6):381-2.
1992: Manuel López-Brea
[Helicobacter pylori].
Enfermedades infecciosas y microbiología clínica 1992;10(6):360-5.
1991: Manuel López-Brea; E Martín; C López-Lavid; Juan Carlos Sanz
Susceptibility of Helicobacter pylori to metronidazole.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(12):1082-3.
1991: M L Jiménez; J Aspa; B Padilla; Julio Ancochea; A González; J Fraga; I Santos; R Martínez; P Gómez Herruz; Manuel López-Brea
Fiberoptic bronchoscopic diagnosis of pulmonary disease in 151 HIV-infected patients with pneumonitis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(6):491-6.
1990: Manuel López-Brea; Juan Carlos Sanz
[Leptospirosis].
Enfermedades infecciosas y microbiología clínica 1990;8(10):597-601.
1990: Manuel López-Brea; Teresa Alarcón
Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(5):345-7.
1990: Juan Carlos Sanz; M Moreno; C de las Cuevas; B Buendía; Manuel López-Brea
[Corynebacterium jeikeium septicemia].
Enfermedades infecciosas y microbiología clínica 1990;8(2):88-90.